男性性腺機能低下症の世界市場：2022年～2026年

世界の男性性腺機能低下症の市場規模は、2022年～2026年の間に6億8,495万米ドルの増加が見込まれ、予測期間中に5.09％のCAGRで成長すると予測されています。

市場を牽引しているのは、性腺機能低下症の発生率の増加、男性性腺機能低下症と治療の選択肢への認知度の高まり、不妊症率の増加です。

当レポートでは、世界の男性性腺機能低下症市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因、課題、および約25社のベンダーをカバーするベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模（2021年）
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• ライバルの脅威
• 市況

第5章 タイプ別の市場セグメンテーション

• 市場セグメント
• タイプ別の比較
• クラインフェルター症候群：市場規模と予測（2021年～2026年）
• カルマン症候群：市場規模と予測（2021年～2026年）
• 下垂体障害：市場規模と予測（2021年～2026年）
• タイプ別の市場機会

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別の情勢

• 地域別のセグメンテーション
• 地域別の比較
• 北米：市場規模と予測（2021年～2026年）
• 欧州：市場規模と予測（2021年～2026年）
• アジア：市場規模と予測（2021年～2026年）
• その他の地域（ROW）：市場規模と予測（2021年～2026年）
• 米国：市場規模と予測（2021年～2026年）
• ドイツ：市場規模と予測（2021年～2026年）
• 中国：市場規模と予測（2021年～2026年）
• 英国：市場規模と予測（2021年～2026年）
• カナダ：市場規模と予測（2021年～2026年）
• 地域情勢別の市場機会

第8章 促進要因・課題・動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱情勢
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Bayer AG
• Eli Lilly and Co.
• Endo International Plc
• Ferring B.V.
• IBSA Institute Biochimique SA
• Lipocine Inc.
• Merck and Co. Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

第11章 付録

Technavio has been monitoring the male hypogonadism market and it is poised to grow by $ 684.95 mn during 2022-2026 progressing at a CAGR of 5.09% during the forecast period. Our report on the male hypogonadism market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in the incidence of hypogonadism, increasing awareness about male hypogonadism and its treatment options, and growth in infertility rates.

The male hypogonadism market analysis includes the type segment and geographic landscape.

Technavio's male hypogonadism market is segmented as below:

By Type

• Klinefelters syndrome
• Kallmann syndrome
• Pituitary disorders

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing inorganic growth strategies likely to fuel the market growth as one of the prime reasons driving the male hypogonadism market growth during the next few years. Also, robust R&D activities fueling the pipeline and treating low testosterone levels could reduce COVID-19 mortality will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on male hypogonadism market covers the following areas:

• Male hypogonadism market sizing
• Male hypogonadism market forecast
• Male hypogonadism market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading male hypogonadism market vendors that include AbbVie Inc., Aytu BioPharma Inc., Bayer AG, Bio Techne Corp., Diurnal Group Plc, Eli Lilly and Co., Endo International Plc, Ferring B.V., IBSA Institute Biochimique SA, Lipocine Inc., Merck and Co. Inc., Perrigo Co. Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Also, the male hypogonadism market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type
• 5.3 Klinefelters syndrome - Market size and forecast 2021-2026
• Exhibit 28: Chart on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
• 5.4 Kallmann syndrome - Market size and forecast 2021-2026
• Exhibit 32: Chart on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
• 5.5 Pituitary disorders - Market size and forecast 2021-2026
• Exhibit 36: Chart on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Pituitary disorders - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Pituitary disorders - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by Type
• Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 China - Market size and forecast 2021-2026
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings
• 10.4 Bayer AG
• Exhibit 92: Bayer AG - Overview
• Exhibit 93: Bayer AG - Business segments
• Exhibit 94: Bayer AG - Key offerings
• Exhibit 95: Bayer AG - Segment focus
• 10.5 Eli Lilly and Co.
• Exhibit 96: Eli Lilly and Co. - Overview
• Exhibit 97: Eli Lilly and Co. - Product / Service
• Exhibit 98: Eli Lilly and Co. - Key offerings
• 10.6 Endo International Plc
• Exhibit 99: Endo International Plc - Overview
• Exhibit 100: Endo International Plc - Business segments
• Exhibit 101: Endo International Plc - Key news
• Exhibit 102: Endo International Plc - Key offerings
• Exhibit 103: Endo International Plc - Segment focus
• 10.7 Ferring B.V.
• Exhibit 104: Ferring B.V. - Overview
• Exhibit 105: Ferring B.V. - Product / Service
• Exhibit 106: Ferring B.V. - Key offerings
• 10.8 IBSA Institute Biochimique SA
• Exhibit 107: IBSA Institute Biochimique SA - Overview
• Exhibit 108: IBSA Institute Biochimique SA - Product / Service
• Exhibit 109: IBSA Institute Biochimique SA - Key offerings
• 10.9 Lipocine Inc.
• Exhibit 110: Lipocine Inc. - Overview
• Exhibit 111: Lipocine Inc. - Product / Service
• Exhibit 112: Lipocine Inc. - Key offerings
• 10.10 Merck and Co. Inc.
• Exhibit 113: Merck and Co. Inc. - Overview
• Exhibit 114: Merck and Co. Inc. - Business segments
• Exhibit 115: Merck and Co. Inc. - Key news
• Exhibit 116: Merck and Co. Inc. - Key offerings
• Exhibit 117: Merck and Co. Inc. - Segment focus
• 10.11 Pfizer Inc.
• Exhibit 118: Pfizer Inc. - Overview
• Exhibit 119: Pfizer Inc. - Product / Service
• Exhibit 120: Pfizer Inc. - Key news
• Exhibit 121: Pfizer Inc. - Key offerings
• 10.12 Teva Pharmaceutical Industries Ltd.
• Exhibit 122: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 123: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 125: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 126: Teva Pharmaceutical Industries Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 127: Inclusions checklist
• Exhibit 128: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 129: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 130: Research methodology
• Exhibit 131: Validation techniques employed for market sizing
• Exhibit 132: Information sources
• 11.5 List of abbreviations
• Exhibit 133: List of abbreviations

Exhibits

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Type
• Exhibits27: Data Table on Comparison by Type
• Exhibits28: Chart on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Pituitary disorders - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Pituitary disorders - Year-over-year growth 2021-2026 (%)
• Exhibits40: Market opportunity by Type ($ million)
• Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits44: Chart on Geographic comparison
• Exhibits45: Data Table on Geographic comparison
• Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits82: Market opportunity By Geographical Landscape ($ million)
• Exhibits83: Impact of drivers and challenges in 2021 and 2026
• Exhibits84: Overview on Criticality of inputs and Factors of differentiation
• Exhibits85: Overview on factors of disruption
• Exhibits86: Impact of key risks on business
• Exhibits87: Vendors covered
• Exhibits88: Matrix on vendor position and classification
• Exhibits89: AbbVie Inc. - Overview
• Exhibits90: AbbVie Inc. - Product / Service
• Exhibits91: AbbVie Inc. - Key offerings
• Exhibits92: Bayer AG - Overview
• Exhibits93: Bayer AG - Business segments
• Exhibits94: Bayer AG - Key offerings
• Exhibits95: Bayer AG - Segment focus
• Exhibits96: Eli Lilly and Co. - Overview
• Exhibits97: Eli Lilly and Co. - Product / Service
• Exhibits98: Eli Lilly and Co. - Key offerings
• Exhibits99: Endo International Plc - Overview
• Exhibits100: Endo International Plc - Business segments
• Exhibits101: Endo International Plc - Key news
• Exhibits102: Endo International Plc - Key offerings
• Exhibits103: Endo International Plc - Segment focus
• Exhibits104: Ferring B.V. - Overview
• Exhibits105: Ferring B.V. - Product / Service
• Exhibits106: Ferring B.V. - Key offerings
• Exhibits107: IBSA Institute Biochimique SA - Overview
• Exhibits108: IBSA Institute Biochimique SA - Product / Service
• Exhibits109: IBSA Institute Biochimique SA - Key offerings
• Exhibits110: Lipocine Inc. - Overview
• Exhibits111: Lipocine Inc. - Product / Service
• Exhibits112: Lipocine Inc. - Key offerings
• Exhibits113: Merck and Co. Inc. - Overview
• Exhibits114: Merck and Co. Inc. - Business segments
• Exhibits115: Merck and Co. Inc. - Key news
• Exhibits116: Merck and Co. Inc. - Key offerings
• Exhibits117: Merck and Co. Inc. - Segment focus
• Exhibits118: Pfizer Inc. - Overview
• Exhibits119: Pfizer Inc. - Product / Service
• Exhibits120: Pfizer Inc. - Key news
• Exhibits121: Pfizer Inc. - Key offerings
• Exhibits122: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits123: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits124: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits125: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits126: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits127: Inclusions checklist
• Exhibits128: Exclusions checklist
• Exhibits129: Currency conversion rates for US$
• Exhibits130: Research methodology
• Exhibits131: Validation techniques employed for market sizing
• Exhibits132: Information sources
• Exhibits133: List of abbreviations